Nebenwirkungen · Lyrica
Lyrica 20 mg/mL oral solution · Abschnitt 4.8 · PDF-Seite 26
HOS-112923 · Präparat HOS-093785
The pregabalin clinical programme involved over 8,900 patients exposed to pregabalin, of whom over 5,600 were in double-blind placebo controlled trials. The most commonly reported adverse reactions were dizziness and somnolence. Adverse reactions were usually mild to moderate in intensity. In all controlled studies, the discontinuation rate due to adverse reactions was 12% for patients receiving pregabalin and 5% for patients receiving placebo. The most common adverse reactions resulting in discontinuation from pregabalin treatment groups were dizziness and somnolence.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-10-13T14:23:00Z · SHA-256 b911bddbab432f8a0fcedb9c67537bff55e0bf53d314c31c88869bca834605af · Passage f0628b730d2ad571569c1887dd33919ae954ffce1d70dbfbf4f2dea5b36a74a9 · Zeichen 0–575 im Abschnitt